Literature DB >> 12842128

Distribution of ORL-1 receptor binding and receptor-activated G-proteins in rat forebrain and their experimental localization in anterior cingulate cortex.

Laura J Sim-Selley1, Leslie J Vogt, Steven R Childers, Brent A Vogt.   

Abstract

Opioid receptor-like (ORL-1) receptors and ORL-1-activated G-proteins are found in high levels in the forebrain, particularly cingulate cortex, an area involved in processing of nociceptive stimuli. [(3)H]nociceptin/orphanin FQ (N/OFQ) and N/OFQ-stimulated [(35)S]GTPgammaS autoradiography in rat brain were used to localize ORL-1 receptors and activated G-proteins, respectively. N/OFQ binding and activated G-proteins were highest in anterior cingulate, agranular insula, piriform, perirhinal and entorhinal cortices; midline and intralaminar thalamic nuclei; and subnuclei of the amygdala and hippocampus. In anterior cingulate area 24, [(3)H]N/OFQ and N/OFQ-stimulated [(35)S]GTPgammaS binding were highest in layers V and VI. The cellular localization of ORL-1 receptors and activated G-proteins in area 24 was examined using two strategies: ibotenic acid injection into the cortex or undercut lesions to remove afferent axons, followed by autoradiography. Ibotenic acid lesions that destroyed neurons in the anterior cingulate cortex decreased [(3)H]N/OFQ binding by 75-80% and reduced N/OFQ-stimulated [(35)S]GTPgammaS binding to basal levels seen in the absence of agonist. Deafferentation lesions increased [(3)H]N/OFQ binding by 40-50%, with no significant change in N/OFQ-stimulated [(35)S]GTPgammaS binding. These data demonstrate that ORL-1 receptors in layer V of anterior cingulate cortex are located on somatodendritic elements and that deafferentation increases ORL-1 receptor binding.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12842128     DOI: 10.1016/s0028-3908(03)00155-2

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  5 in total

1.  Increased opioid receptor binding and G protein coupling in the accumbens and ventral tegmental area of postnatal day 2 rats.

Authors:  Yanning Hou; Mariana M Belcheva; Amy L Clark; Daniel S Zahm; Carmine J Coscia
Journal:  Neurosci Lett       Date:  2005-11-21       Impact factor: 3.046

2.  Roles of K+ and cation channels in ORL-1 receptor-mediated depression of neuronal excitability and epileptic activities in the medial entorhinal cortex.

Authors:  Huiming Li; Binqi Hu; Hao-Peng Zhang; Cody A Boyle; Saobo Lei
Journal:  Neuropharmacology       Date:  2019-04-15       Impact factor: 5.250

3.  Agonist-selective NOP receptor phosphorylation correlates in vitro and in vivo and reveals differential post-activation signaling by chemically diverse agonists.

Authors:  Anika Mann; Lionel Moulédous; Carine Froment; Patrick R O'Neill; Pooja Dasgupta; Thomas Günther; Gloria Brunori; Brigitte L Kieffer; Lawrence Toll; Michael R Bruchas; Nurulain T Zaveri; Stefan Schulz
Journal:  Sci Signal       Date:  2019-03-26       Impact factor: 8.192

Review 4.  Therapeutic potentials of NOP and MOP receptor coactivation for the treatment of pain and opioid abuse.

Authors:  Norikazu Kiguchi; Huiping Ding; Mei-Chuan Ko
Journal:  J Neurosci Res       Date:  2020-04-07       Impact factor: 4.433

5.  Knock-In Mice with NOP-eGFP Receptors Identify Receptor Cellular and Regional Localization.

Authors:  Akihiko Ozawa; Gloria Brunori; Daniela Mercatelli; Jinhua Wu; Andrea Cippitelli; Bende Zou; Xinmin Simon Xie; Melissa Williams; Nurulain T Zaveri; Sarah Low; Grégory Scherrer; Brigitte L Kieffer; Lawrence Toll
Journal:  J Neurosci       Date:  2015-08-19       Impact factor: 6.167

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.